The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges
Chang Song, Dong-Sheng Lu, Chun-Yan Zhao, Zhan-Yu Xu, Hua-Jian Peng, Xin-Lin Li, Hai-Yu Zeng, Jun-Hong Li, Jian-Ji Guo, Nuo Yang · 2026
Read The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges by Chang Song, Dong-Sheng Lu, Chun-Yan Zhao, Zhan-Yu Xu, Hua-Jian Peng, Xin-Lin Li, Hai-Yu Zeng, Jun-Hong Li, Jian-Ji Guo, Nuo Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13315371.txt.
Description
Chang Song and nine co-authors chart the worldwide clinical trial landscape for cell therapies against lung cancer. Four hundred fifty-two interventional trials, gathered by cross-referencing registries and screening out non-cellular work, form the dataset. Two researchers extracted the data independently to keep it honest.
Trial activity entered rapid growth in twenty sixteen and peaked in twenty twenty-four, by their count. The analysis breaks the field down by year, country, sponsor type, cell type, target, phase, and status. Patterns in those numbers reveal what drives the field and where translation stalls. Scientific challenges, including target choice and trial design, get a dedicated discussion. The authors intend the map as a reference for researchers, policymakers, and clinicians.
Catalog record
| CREATOR | Chang Song, Dong-Sheng Lu, Chun-Yan Zhao, Zhan-Yu Xu, Hua-Jian Peng, Xin-Lin Li, Hai-Yu Zeng, Jun-Hong Li, Jian-Ji Guo, Nuo Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |